Resources
About Us
Home Report
Store
VNA and PACS Market
VNA and PACS Market by Procurement (PACS [Departmental {Radiology, Mammography, Dental} Enterprise] VNA [Enterprise, Multi-site] [CT, Angiography, MRI, Ultrasound]), Delivery (On Premise, Cloud, Hybrid), Vendor Type, End User - Global Forecast to 2031
Report ID:MRHC - 10424 Pages: 250 Mar-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 48 HoursThe VNA and PACS Market was valued at $3.72 billion in 2023. This market is expected to reach $6.5 billion by 2031, from an estimated $4 billion in 2024, at a CAGR of 7.2% during the forecast period 2024-2031.
VNA and PACS Market Size & Forecast
Vendor Neutral Archive (VNA) & Picture Archiving and Communication System (PACS) are medical image management solutions used for aiding diagnosis, comparing images between patients or within the same patient at different time points to assess the progress of the disease, and evaluating prognosis. These solutions are used to replace physical archiving by storing all medical image datasets digitally in an organized manner. Such solutions also allow the integration of medical image data with patient data in other records, such as electronic health records, health information systems, and radiology information systems (RIS).
The growth of this market is driven by factors such as the increasing investments in medical imaging technologies, growing demand for imaging equipment, technological advancements in diagnostic imaging modalities, rising geriatric population, thereby increasing imaging volumes, growing big data presence in healthcare, and growing healthcare IT & EHR adoption. Moreover, the integration of PACS/VNA with EMR, penetration of Artificial intelligence (AI) in medical imaging, rising adoption of hybrid & cloud-based medical imaging solutions, and rapidly growing telehealth market are expected to offer significant market growth opportunities.
However, the longer product lifecycle of VNA and budgetary constraints restrain the market’s growth. Additionally, data migration and lack of interoperability pose challenges to the market’s growth.
The Increasing Investments in Medical Imaging Technologies is Driving the Market’s Growth
Medical imaging uses various imaging modalities, such as X-ray, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI), to diagnose diseases. It also helps view and analyze the body’s internal conditions. Factors driving investments in medical imaging technologies include efforts by government bodies to modernize imaging facilities and research, the proliferation of diagnostic imaging centers, technological advancements in diagnostic imaging modalities, and patients’ increasing preference for minimally invasive treatments.
Growth in the utilization of diagnostic imaging services has led to the generation of huge volumes of images that require tools such as PACS and VNA for proper storage, organized analysis, archival, sharing, and management. Funding from government bodies and investments from private organizations in the medical imaging field is critical to the development & implementation of innovative imaging technologies, modernizing imaging facilities, improving patients’ quality of life, and opening up new areas of scientific discovery. Some of the related key developments in the medical imaging space are as follows:
- In September 2023, GE HealthCare Technologies Inc. (U.S.) received more than USD 44 million in funding from the Bill & Melinda Gates Foundation (U.S.) to develop accessible, artificial intelligence (AI)-assisted ultrasound imaging auto-assessment tools and to make ultrasound more available in low-and-middle-income countries.
- In October 2021, DeepSight Technology, Inc. (U.S.) announced raising USD 25 million in Series A funding. DeepSight Technology aims to enhance non-invasive & invasive medical imaging for multiple diagnostic procedures. The company plans to use the funds to advance its medical imaging technology platform and scale its business.
- In July 2021, Exo Imaging, Inc (U.S.) raised USD 220 million in Series C funding to support the company’s plan to deliver a smartphone-connected ultrasound probe, an advanced technology in the medical imaging field.
Such investments in medical imaging technologies are expected to increase the adoption of medical imaging modalities in the coming years, driving the growth of the VNA & PACS market.
Click here to: Get Free Sample Pages of this Report
Integration of PACS/VNA with EMR to Offer Market Growth Opportunities
With the advancement in imaging modalities and the enhanced role of imaging in patient care management, there is a rapid increase in image volumes in radiology, cardiology, oncology, and other departments. Earlier, medical images were analogical and stored on film; with technological advancements, modern imaging modalities, and image management systems, it is possible to turn traditional film-based radiology into a filmless operation. All medical images today can be initially generated in digital form and stored in PACS. Digital storage results in a significant cost reduction while increasing available space in the facility and improving the overall efficiency of imaging centers.
EMR and PACS can view images using the EMR enterprise PACS/VNA integration. Therefore, companies have developed integrated platforms. For instance, the INFINITT Healthcare Platform (IHP) of INFINITT North America Inc. (U.S.) offers full integration with EMRs for content sharing and display. The platform fully supports various data formats beyond DICOM, managing DICOM and non-DICOM data on an Oracle database. Similarly, Change Healthcare’s (U.S.) Conserus Image Repository integrates with all major PACS, cardiac PACS, and EMR vendors through a standard EMR web API.
Innovation in integration technology has enabled the flexibility to connect this gap with improved interface implementation. Users can now use a standard web browser to access medical imaging studies within the patient's comprehensive medical records/charts. Large health systems have different EMRs and different imaging solutions across many departments. Integrating images and having them in one repository is in high demand. Increasing demand for collaborative and patient-centered care serves as an opportunity for the VNA & PACS with EMR solutions.
Key Findings in the VNA & PACS Market Study:
The Departmental PACS Segment is Expected to Account for the Larger Share of the Market in 2024
Among the procurement models of PACS covered in this report, in 2024, the departmental PACS segment is expected to account for the larger share of the PACS market. The large market share of this segment can be attributed to the increasing adoption of these PACS to process large volumes of images. Radiology departments use these PACS due to their ability to solve radiology-related issues by digitalizing the traditional process, improving efficiency, ensuring data privacy & security, and enhancing image access. Most PACS have image viewing & annotation tools built into them to obtain proper conclusions and plan treatment, contributing to their widespread adoption.
The On-Premise PACS Segment is Expected to Account for the Largest Share of the Market in 2024
Among the delivery modes for PACS covered in this report, in 2024, the on-premise PACS segment is expected to account for the largest share of the PACS market. The large market share of this segment can be attributed to the various advantages offered by on-premise PACS, such as high security, control over images, and comparatively lower latency than web/cloud-based PACS are the factors contributing to the significant market share of this segment.
The Enterprise VNA Segment is Expected to Account for the Larger Share of the Market in 2024
Among the procurement models of VNA covered in this report, in 2024, the enterprise VNA segment is expected to account for the larger share of the VNA market. The large market share of this segment can be attributed to the increasing need to aggregate data across multiple sites to improve care coordination across sites of care. Moreover, the emergence of Integrated Delivery Networks (IDNs), Accountable Care Organizations (ACOs), and Health Information Exchanges (HIE) and rapid globalization and consolidation further propels the demand for collaborated care & easy access and sharing of data across healthcare settings. Additionally, multiple hospitals connecting to central repositories and patient mobility between local hospitals and centers are expected to drive the growth of the multi-site VNA market.
The On-Premise VNA Segment is Expected to Account for the Largest Share of the Market in 2024
Among the delivery models covered in this report, in 2024, the on-premise VNA segment is expected to account for the largest share of the VNA market. The benefit of the on-premise VNA delivery model, specifically for organizations that are migrating or upgrading from one system to another, is the ability to reuse existing servers and storage hardware. Hardware reuse alleviates costs, particularly for smaller organizations that distribute the cost of server hardware over a relatively small number of users. Thus, despite the high upfront cost of installation, on-premise models are still preferred by healthcare organizations, mainly due to patient data security and confidentiality, contributing to the significant market share of this segment.
The Computed Tomography (CT) Segment is Expected to Account for the Largest Share of the Market in 2024
Among the imaging modalities covered in this report, in 2024, the Computed Tomography (CT) segment is expected to account for the largest share of the VNA & PACS market. The large market share of this segment can be attributed to the rising demand for imaging services and technological advancement in CT having drastically boosted image resolution, quality, and diagnostic capabilities. These improvements have turned CT scanning into a vital tool in medical imaging, resulting in higher demand for storage and administration solutions such as VNA and PACS.
The Independent Software Vendors Segment is Expected to Account for the Largest Share of the Market in 2024
Among the vendor types covered in this report, in 2024, the independent software vendors segment is expected to account for the largest share of the VNA & PACS market. The large market share of this segment can be attributed to the increasing number of hospitals, community centers, and diagnostic imaging centers are turning towards independent software vendors such as Merge Healthcare (IBM), Dejarnette Research Systems, Hyland Software (Acuo), and TeraMedica (Fujifilm) for their vast experience and better functionality, scalability, integration, and support provided for VNA.
The Hospitals Segment is Expected to Account for the Largest Share of the Market in 2024
Among the end users covered in this report, in 2024, the hospitals segment is expected to account for the largest share of the VNA & PACS market. This segment’s large market share can be attributed to the higher patient visits and admissions, efficient management of patient data, and initiatives undertaken to implement advanced technologies.
Asia-Pacific: Fastest-growing Regional Market
The market in Asia-Pacific is projected to register the highest growth rate during the forecast period. The growth of this regional market can be attributed to the rising investment in the healthcare sector for improving healthcare infrastructure and digital health, the adoption of advanced imaging modalities into the healthcare industry, and the presence of major VNA & PACS software developers in countries such as China, India, Singapore, and Japan, and technological advancements related to diagnostic imaging, and, government initiatives aiming to increase the utilization of EMR and telehealth services.
VNA and PACS Market: Competitive Analysis
The report offers a competitive landscape based on an extensive assessment of the software offerings and geographic presence of leading market players and the key growth strategies adopted by them over the past three to four years. The key players profiled in the VNA & PACS market report are Novarad Corporation (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Agfa-Gevaert NV (Belgium), Mach7 Technologies (Australia), GE HealthCare Technologies Inc. (U.S.), Fujifilm Holdings Corporation (Japan), Sectra AB (Sweden), Bridgehead Software, Ltd. (U.K.), INFINITT Healthcare Co., Ltd. (South Korea), Hyland Software, Inc. (U.S.), ASPYRA, LLC (U.S.), Merative L.P. (U.S.), SoftTeam Solutions Pvt Ltd. (India), Carestream Health, Inc. (U.S.), and Neusoft Corporation (China).
VNA and PACS Market Report Summary:
|
Particulars |
Details |
|
Number of Pages |
~250 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
7.2% |
|
Estimated Market Size (Value) |
$6.50 billion by 2031 |
|
Segments Covered |
By Procurement Model
By Delivery Mode
By Procurement Model
By Delivery Mode
By Imaging Modality
By Vendor Type
By End User
|
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, Italy, U.K., Spain, Switzerland, Rest of Europe) Asia–Pacific (India, China, Japan, South Korea, Australia, Rest of Asia–Pacific), Latin America (Brazil, Mexico, Rest of Latin America), Middle East & Africa. |
|
Key Companies |
Novarad Corporation (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Agfa-Gevaert NV (Belgium), Mach7 Technologies (Australia), GE HealthCare Technologies Inc. (U.S.), Fujifilm Holdings Corporation (Japan), Sectra AB (Sweden), Bridgehead Software, Ltd. (U.K.), INFINITT Healthcare Co., Ltd. (South Korea), Hyland Software, Inc. (U.S.), ASPYRA, LLC (U.S.), Merative L.P. (U.S.), SoftTeam Solutions Pvt Ltd. (India), Carestream Health, Inc. (U.S.), and Neusoft Corporation (China). |
Key questions answered in the report:
This study offers a detailed assessment of the VNA & PACS market and analyzes the market sizes & forecasts based on procurement model, delivery mode, imaging modality, vendor type, and end user. This report also involves the value analysis of various segments and subsegments of the VNA & PACS market at the regional and country levels.
The VNA & PACS market is projected to reach $6.50 billion by 2031, at a CAGR of 7.2% during the forecast period.
Among the procurement models covered in this report, the departmental PACS segment is expected to account for the largest share of the market in 2024. This segment's large market share is attributed to the increasing adoption of these PACS to process large volumes of images.
Among the delivery models covered in this report, in 2024, the On-premise PACS segment is expected to account for the largest share of the PACS market. The large market share of this segment can be attributed to the various advantages offered by on-premise PACS, such as high security, control over images, and comparatively lower latency than web/cloud-based PACS are the factors contributing to the significant market share of this segment.
The growth of this market is driven by factors such as the increasing investments in medical imaging technologies, growing demand for imaging equipment, technological advancements in diagnostic imaging modalities, rising geriatric imaging volumes, growing big data presence in healthcare, and growing healthcare IT & EHR adoption. Moreover, the integration of PACS/VNA with EMR, penetration of artificial intelligence (AI) in medical imaging, rising adoption of hybrid & cloud-based medical imaging solutions, and rapidly growing telehealth market are expected to offer significant market growth opportunities.
The key players profiled in the VNA & PACS market report are Novarad Corporation (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Agfa-Gevaert NV (Belgium), Mach7 Technologies (Australia), GE HealthCare Technologies Inc. (U.S.), Fujifilm Holdings Corporation (Japan), Sectra AB (Sweden), Bridgehead Software, Ltd. (U.K.), INFINITT Healthcare Co., Ltd. (South Korea), Hyland Software, Inc. (U.S.), ASPYRA, LLC (U.S.), Merative L.P. (U.S.), SoftTeam Solutions Pvt Ltd. (India), Carestream Health, Inc. (U.S.), and Neusoft Corporation (China)..
Emerging economies, such as China and India, are expected to provide significant growth opportunities for market players due to their growing investments in medical imaging technologies and demand for imaging equipment.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Increasing Investments in Medical Imaging Technologies
4.2.2. Growing Demand for Medical Imaging Equipment
4.2.3. Technological Advancements in Diagnostic Imaging Modalities
4.2.4 Rising Geriatric Population
4.2.5. Rapidly Growing Big Data in Healthcare
4.2.6. Growing Healthcare IT & EHR Adoption
4.3. Restraints
4.3.1. Longer Product Lifecycle of VNA
4.3.2. Budgetary Constraints
4.4. Opportunities
4.4.1. Integration of PACS/VNA with EMR
4.4.2. Penetration of Artificial Intelligence (AI) in Medical Imaging
4.4.3. Rising Adoption of Hybrid & Cloud-Based Medical Imaging Solutions
4.4.4. Rapidly Growing Telehealth Market
4.5. Challenges
4.5.1. Data Migration
4.5.2. Lack of Interoperability
4.6. Trends
4.6.1. Digital Health Initiatives in All Over the World
4.6.2. Growing the Utilization of Mobile Devices to Access VNA & PACS Systems.
4.7. Factor Analysis
4.8. Regulatory Analysis
4.9. Parent/Adjacent Market Analysis
4.10. Porter’s Five Forces Analysis
5. PACS Market Assessment—by Procurement Model
5.1. Overview
5.2. Departmental PACS
5.2.1. Radiology PACS
5.2.2. Cardiology PACS
5.2.3. Mammography PACS
5.2.3.1. Traditional Mammography PACS
5.2.3.2. Vendor Neutral Mammography PACS
5.2.4. Dental PACS
5.2.5. Other Departmental PACS
5.3. Enterprise PACS
6. PACS Market Assessment—by Delivery Mode
6.1. Overview
6.2. On-Premise PACS
6.3. Web/Cloud-Based PACS
7. VNA Market Assessment—by Procurement Model
7.1. Overview
7.2. Enterprise VNA
7.2.1. Multi-Departmental VNA
7.2.2. Multi-Site VNA
7.3. Departmental VNA
8. VNA Market Assessment—by Delivery Mode
8.1. Overview
8.2. On-Premise VNA
8.3. Hybrid VNA
8.4. Web/Cloud-Based VNA
9. VNA & PACS Market Assessment—by Imaging Modality
9.1. Overview
9.2. Computed Tomography (CT)
9.3. Angiography
9.4. Mammography
9.5. Magnetic Resonance Imaging (MRI)
9.6. Ultrasound
9.7. Other Imaging Modalities
10. VNA & PACS Market Assessment—by Vendor Type
10.1. Overview
10.2. Independent Software Vendors
10.3. PACS Vendors
10.4. Infrastructure Vendors
11. VNA & PACS Market Assessment—by End User
11.1. Overview
11.2. Hospitals
11.3. Diagnostic Imaging Centers
11.4. Ambulatory Surgical Centers
11.5. Other End Users
12. VNA & PACS Market Assessment—by Geography
12.1. Overview
12.2. North America
12.2.1. U.S.
12.2.2. Canada
12.3. Europe
12.3.1. Germany
12.3.2. France
12.3.3. U.K.
12.3.4. Italy
12.3.5. Spain
12.3.6. Switzerland
12.3.7. Rest of Europe
12.4. Asia-Pacific
12.4.1. Japan
12.4.2. China
12.4.3. India
12.4.4. South Korea
12.4.5. Australia
12.4.6. Rest of Asia-Pacific
12.5. Latin America
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Middle East & Africa
13. Competition Analysis
13.1. Overview
13.2. Key Growth Strategies
13.3. Competitive Benchmarking
13.4. Competitive Dashboard
13.4.1. Industry Leaders
13.4.2. Market Differentiators
13.4.3. Vanguards
13.4.4. Emerging Companies
13.5. Market Share Analysis/Market Rankings, by Key Players (2023)
13.5.1. Market Share Analysis: Picture Archiving Communication Systems (PACS) Industry
13.5.2. Market Share Analysis: Vendor Neutral Archive (VNA) Industry
14. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
14.1. Novarad Corporation
14.2. Koninklijke Philips N.V.
14.3. Siemens Healthineers AG
14.4. Agfa-Gevaert NV
14.5. Mach7 Technologies
14.6. GE HealthCare Technologies Inc.
14.7. Fujifilm Holdings Corporation
14.8. Sectra AB
14.9. Bridgehead Software, Ltd.
14.10. INFINITT Healthcare Co., Ltd.
14.11. Hyland Software, Inc.
14.12. ASPYRA, LLC
14.13. Merative L.P.
14.14. SoftTeam Solutions Pvt Ltd.
14.15. Carestream Health, Inc.
14.16. Neusoft Corporation
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
15. Appendix
15.1. Available Customization
15.2. Related Reports
List of Tables
Table 1 Global PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 2 Global Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 3 Global Departmental PACS Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Global Radiology PACS Market, by Country/Region, 2022–2031 (USD Million)
Table 5 Global Cardiology PACS Market, by Country/Region, 2022–2031 (USD Million)
Table 6 Global Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 7 Global Mammography PACS Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Global Traditional Mammography PACS Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Vendor Neutral Mammography PACS Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Dental PACS Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Other Departmental PACS Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Global Enterprise PACS Market, by Country/Region, 2022–2031 (USD Million)
Table 13 Global PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 14 Global On-Premise PACS Market, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Web/Cloud-Based PACS Market, by Country/Region, 2022–2031 (USD Million)
Table 16 Global VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 17 Global Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 18 Global Enterprise VNA Market, by Country/Region, 2022–2031 (USD Million)
Table 19 Global Multi-Departmental VNA Market, by Country/Region, 2022–2031 (USD Million)
Table 20 Global Multi-Site VNA Market, by Country/Region, 2022–2031 (USD Million)
Table 21 Global Departmental VNA Market, Country/Region, 2022–2031 (USD Million)
Table 22 Global VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 23 Global On-Premise VNA Market, by Country/Region, 2022–2031 (USD Million)
Table 24 Global Hybrid VNA Market, by Country/Region, 2022–2031 (USD Million)
Table 25 Global Web/Cloud-Based VNA Market, by Country/Region, 2022–2031 (USD Million)
Table 26 Global VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 27 Global VNA & PACS Market for Computed Tomography (CT), by Country/Region, 2022–2031 (USD Million)
Table 28 Global VNA & PACS Market for Angiography, by Country/Region, 2022–2031 (USD Million)
Table 29 Global VNA & PACS Market for Mammography, by Country/Region, 2022–2031 (USD Million)
Table 30 Global VNA & PACS Market for Magnetic Resonance Imaging (MRI), by Country/Region, 2022–2031 (USD Million)
Table 31 Global VNA & PACS Market for Ultrasound, by Country/Region, 2022–2031 (USD Million)
Table 32 Global VNA & PACS Market for Other Imaging Modalities, by Country/Region, 2022–2031 (USD Million)
Table 33 Global VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 34 Global VNA & PACS Market for Independent Software Vendors, by Country/Region, 2022–2031 (USD Million)
Table 35 Global VNA & PACS Market for PACS Vendors, by Country/Region, 2022–2031 (USD Million)
Table 36 Global VNA & PACS Market for Infrastructure Vendors, by Country/Region, 2022–2031 (USD Million)
Table 37 Global VNA & PACS Market, by End User, 2022–2031 (USD Million)
Table 38 Global VNA & PACS Market for Hospitals, by Country/Region, 2022–2031 (USD Million)
Table 39 Global VNA & PACS Market for Diagnostic Imaging Centers, by Country/Region, 2022–2031 (USD Million)
Table 40 Global VNA & PACS Market for Ambulatory Surgical Centers, by Country/Region, 2022–2031 (USD Million)
Table 41 Global VNA & PACS Market for Other End Users, by Country/Region, 2022–2031 (USD Million)
Table 42 Global VNA & PACS Market, by Country/Region, 2022–2031 (USD Million)
Table 43 North America: VNA & PACS Market, by Country, 2022–2031 (USD Million)
Table 44 North America: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 45 North America: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 46 North America: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 47 North America: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 48 North America: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 49 North America: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 50 North America: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 51 North America: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 52 North America: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 53 North America: VNA & PACS Market, by End User, 2022–2031 (USD Million)
Table 54 U.S.: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 55 U.S.: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 56 U.S.: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 57 U.S.: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 58 U.S.: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 59 U.S.: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 60 U.S.: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 61 U.S.: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 62 U.S.: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 63 U.S.: VNA & PACS Market, by End User, 2022–2031 (USD Million)
Table 64 Canada: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 65 Canada: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 66 Canada: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 67 Canada: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 68 Canada: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 69 Canada: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 70 Canada: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 71 Canada: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 72 Canada: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 73 Canada: VNA & PACS Market, by End User, 2022–2031 (USD Million)
Table 74 Europe: VNA & PACS Market, by Country/Region, 2022–2031 (USD Million)
Table 75 Europe: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 76 Europe: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 77 Europe: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 78 Europe: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 79 Europe: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 80 Europe: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 81 Europe: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 82 Europe: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 83 Europe: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 84 Europe: VNA & PACS Market, by End User, 2022–2031 (USD Million)
Table 85 Germany: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 86 Germany: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 87 Germany: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 88 Germany: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 89 Germany: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 90 Germany: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 91 Germany: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 92 Germany: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 93 Germany: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 94 Germany: VNA & PACS Market, by End User, 2022–2031 (USD Million
Table 95 France: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 96 France: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 97 France: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 98 France: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 99 France: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 100 France: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 101 France: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 102 France: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 103 France: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 104 France: VNA & PACS Market, by End User, 2022–2031 (USD Million)
Table 105 U.K.: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 106 U.K.: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 107 U.K.: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 108 U.K.: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 109 U.K.: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 110 U.K.: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 111 U.K.: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 112 U.K.: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 113 U.K.: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 114 U.K.: VNA & PACS Market, by End User, 2022–2031 (USD Million)
Table 115 Italy: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 116 Italy: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 117 Italy: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 118 Italy: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 119 Italy: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 120 Italy: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 121 Italy: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 122 Italy: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 123 Italy: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 124 Italy: VNA & PACS Market, by End User, 2022–2031 (USD Million
Table 125 Spain: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 126 Spain: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 127 Spain: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 128 Spain: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 129 Spain: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 130 Spain: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 131 Spain: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 132 Spain: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 133 Spain: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 134 Spain: VNA & PACS Market, by End User, 2022–2031 (USD Million
Table 135 Switzerland: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 136 Switzerland: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 137 Switzerland: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 138 Switzerland: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 139 Switzerland: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 140 Switzerland: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 141 Switzerland: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 142 Switzerland: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 143 Switzerland: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 144 Switzerland: VNA & PACS Market, by End User, 2022–2031 (USD Million
Table 145 Rest of Europe: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 146 Rest of Europe: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 147 Rest of Europe: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 148 Rest of Europe: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 149 Rest of Europe: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 150 Rest of Europe: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 151 Rest of Europe: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 152 Rest of Europe: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 153 Rest of Europe: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 154 Rest of Europe: VNA & PACS Market, by End User, 2022–2031 (USD Million)
Table 155 Asia–Pacific: VNA & PACS Market, by Country/Region, 2022–2031 (USD Million)
Table 156 Asia–Pacific: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 157 Asia–Pacific: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 158 Asia–Pacific: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 159 Asia–Pacific: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 160 Asia–Pacific: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 161 Asia–Pacific: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 162 Asia–Pacific: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 163 Asia–Pacific: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 164 Asia–Pacific: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 165 Asia–Pacific: VNA & PACS Market, by End User, 2022–2031 (USD Million)
Table 166 Japan: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 167 Japan: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 168 Japan: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 169 Japan: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 170 Japan: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 171 Japan: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 172 Japan: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 173 Japan: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 174 Japan: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 175 Japan: VNA & PACS Market, by End User, 2022–2031 (USD Million
Table 176 China: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 177 China: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 178 China: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 179 China: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 180 China: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 181 China: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 182 China: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 183 China: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 184 China: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 185 China: VNA & PACS Market, by End User, 2022–2031 (USD Million)
Table 186 India: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 187 India: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 188 India: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 189 India: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 190 India: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 191 India: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 192 India: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 193 India: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 194 India: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 195 India: VNA & PACS Market, by End User, 2022–2031 (USD Million)
Table 196 South Korea: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 197 South Korea: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 198 South Korea: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 199 South Korea: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 200 South Korea: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 201 South Korea: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 202 South Korea: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 203 South Korea: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 204 South Korea: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 205 South Korea: VNA & PACS Market, by End User, 2022–2031 (USD Million)
Table 206 Australia: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 207 Australia: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 208 Australia: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 209 Australia: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 210 Australia: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 211 Australia: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 212 Australia: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 213 Australia: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 214 Australia: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 215 Australia: VNA & PACS Market, by End User, 2022–2031 (USD Million)
Table 216 Rest of Asia-Pacific: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 217 Rest of Asia-Pacific: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 218 Rest of Asia-Pacific: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 219 Rest of Asia-Pacific: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 220 Rest of Asia-Pacific: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 221 Rest of Asia-Pacific: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 222 Rest of Asia-Pacific: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 223 Rest of Asia-Pacific: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 224 Rest of Asia-Pacific: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 225 Rest of Asia-Pacific: VNA & PACS Market, by End User, 2022–2031 (USD Million)
Table 226 Latin America: VNA & PACS Market, by Country/Region, 2022–2031 (USD Million)
Table 227 Latin America: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 228 Latin America: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 229 Latin America: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 230 Latin America: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 231 Latin America: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 232 Latin America: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 233 Latin America: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 234 Latin America: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 235 Latin America: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 236 Latin America: VNA & PACS Market, by End User, 2022–2031 (USD Million)
Table 237 Brazil: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 238 Brazil: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 239 Brazil: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 240 Brazil: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 241 Brazil: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 242 Brazil: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 243 Brazil: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 244 Brazil: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 245 Brazil: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 246 Brazil: VNA & PACS Market, by End User, 2022–2031 (USD Million
Table 247 Mexico: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 248 Mexico: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 249 Mexico: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 250 Mexico: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 251 Mexico: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 252 Mexico: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 253 Mexico: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 254 Mexico: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 255 Mexico: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 256 Mexico: VNA & PACS Market, by End User, 2022–2031 (USD Million)
Table 257 Rest of Latin America: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 258 Rest of Latin America: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 259 Rest of Latin America: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 260 Rest of Latin America: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 261 Rest of Latin America: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 262 Rest of Latin America: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 263 Rest of Latin America: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 264 Rest of Latin America: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 265 Rest of Latin America: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 266 Rest of Latin America: VNA & PACS Market, by End User, 2022–2031 (USD Million)
Table 267 Middle East & Africa: PACS Market, by Procurement Model, 2022–2031 (USD Million)
Table 268 Middle East & Africa: Departmental PACS Market, by Type, 2022–2031 (USD Million)
Table 269 Middle East & Africa: Mammography PACS Market, by Type, 2022–2031 (USD Million)
Table 270 Middle East & Africa: PACS Market, by Delivery Mode, 2022–2031 (USD Million)
Table 271 Middle East & Africa: VNA Market, by Procurement Model, 2022–2031 (USD Million)
Table 272 Middle East & Africa: Enterprise VNA Market, by Type, 2022–2031 (USD Million)
Table 273 Middle East & Africa: VNA Market, by Delivery Mode, 2022–2031 (USD Million)
Table 274 Middle East & Africa: VNA & PACS Market, by Imaging Modality, 2022–2031 (USD Million)
Table 275 Middle East & Africa: VNA & PACS Market, by Vendor Type, 2022–2031 (USD Million)
Table 276 Middle East & Africa: VNA & PACS Market, by End User, 2022–2031 (USD Million)
Table 277 Recent Developments, by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Size Estimation
Figure 7 Global PACS Market, by Procurement Model, 2024 VS. 2031 (USD Million)
Figure 8 Global PACS Market, by Delivery Mode, 2024 VS. 2031 (USD Million)
Figure 9 Global VNA Market, by Procurement Model, 2024 VS. 2031 (USD Million)
Figure 10 Global VNA Market, by Delivery Mode, 2024 VS. 2031 (USD Million)
Figure 11 Global VNA & PACS Market, by Imaging Modality, 2024 VS. 2031 (USD Million)
Figure 12 Global VNA & PACS Market, by Vendor Type, 2024 VS. 2031 (USD Million)
Figure 13 Global VNA & PACS Market, by End User, 2024 VS. 2031 (USD Million)
Figure 14 Global VNA & PACS Market, by Geography
Figure 15 Impact Analysis: VNA & PACS Market
Figure 16 Global PACS Market, by Procurement Model, 2024 VS. 2031 (USD Million)
Figure 17 Global PACS Market, by Delivery Mode, 2024 VS. 2031 (USD Million)
Figure 18 Global VNA Market, by Procurement Model, 2024 VS. 2031 (USD Million)
Figure 19 Global VNA Market, by Delivery Mode, 2024 VS. 2031 (USD Million)
Figure 20 Global VNA & PACS Market, by Imaging Modality, 2024 VS. 2031 (USD Million)
Figure 21 Global VNA & PACS Market, by Vendor Type, 2024 VS. 2031 (USD Million)
Figure 22 Global VNA & PACS Market, by End User, 2024 VS. 2031 (USD Million)
Figure 23 Global VNA & PACS Market, by Geography, 2024 VS. 2031 (USD Million)
Figure 24 North America: VNA & PACS Market Snapshot
Figure 25 Europe: VNA & PACS Market Snapshot
Figure 26 Asia-Pacific: VNA & PACS Market Snapshot
Figure 27 Latin America: VNA & PACS Market Snapshot
Figure 28 Key Growth Strategies Adopted by Leading Players, 2020–2024
Figure 29 Global VNA & PACS Market: Competitive Benchmarking, by Procurement Model
Figure 30 Global VNA & PACS Market: Competitive Benchmarking, by Geography
Figure 31 Global VNA & PACS Market: Vendor Dashboard
Figure 32 Market Share Analysis: Global VNA & PACS Market, 2023
Figure 33 Koninklijke Philips N.V.: Financial Overview (2023)
Figure 34 Siemens Healthineers AG: Financial Overview (2023)
Figure 35 Agfa-Gevaert NV: Financial Overview (2023)
Figure 36 Mach7 Technologies: Financial Overview (2023)
Figure 37 GE HealthCare Technologies Inc.: Financial Overview (2023)
Figure 38 Fujifilm Holdings Corporation: Financial Overview (2023)
Figure 39 Sectra AB: Financial Overview (2023)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
India VNA and PACS Market - Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Sep-2024
DNA Sequencing Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Aug-2024
China VNA and PACS Market - Opportunity Analysis and Industry Forecast (2018-2023)
Published Date: Mar-2019
African Forensic DNA Testing Market - Opportunity Analysis and Industry Forecast (2019-2025)
Published Date: Nov-2019
Medical Image Management Market - Global Opportunity Analysis and Industry Forecast (2023-2030)
Published Date: Jan-2023
